Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 3/20 | 0.81 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.81 |
| ▸ | PPARG | P37231 | 4/20 | 0.72 |
| ▸ | PPARD | Q03181 | 4/20 | 0.72 |
| ▸ | PPARA | Q07869 | 4/20 | 0.72 |
| ▸ | F7 | P08709 | 4/20 | 0.72 |
| ▸ | F3 | P13726 | 4/20 | 0.72 |
| ▸ | TERT | O14746 | 3/20 | 0.72 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.72 |
| ▸ | FABP4 | P15090 | 3/20 | 0.72 |
| ▸ | MAPT | P10636 | 2/20 | 0.72 |
| ▸ | BLM | P54132 | 2/20 | 0.72 |
| ▸ | LMNA | P02545 | 2/20 | 0.72 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.72 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.72 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.72 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.72 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.72 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16680870 | 1.00 | FFAR1 (0.81) | FFAR1FFAR4PPARGPPARDPPARA | |
| SCHEMBL15285528 | 1.00 | FFAR1 (0.81) | FFAR1FFAR4PPARGPPARDPPARA | |
| SCHEMBL16680871 | 1.00 | FFAR1 (0.81) | FFAR1FFAR4PPARGPPARDPPARA | |
| SCHEMBL18955897 | 1.00 | FFAR1 (0.81) | FFAR1FFAR4PPARGPPARDPPARA | |
| SCHEMBL18955898 | 1.00 | FFAR1 (0.81) | FFAR1FFAR4PPARGPPARDPPARA | |
| SCHEMBL18258531 | 1.00 | FFAR1 (0.81) | FFAR1FFAR4PPARGPPARDPPARA | |
| SCHEMBL18258529 | 1.00 | FFAR1 (0.81) | FFAR1FFAR4PPARGPPARDPPARA | |
| SCHEMBL7670145 | 1.00 | FFAR1 (0.81) | FFAR1FFAR4PPARGPPARDPPARA | |
| SCHEMBL21570587 | 1.00 | FFAR1 (0.81) | FFAR1FFAR4PPARGPPARDPPARA | |
| SCHEMBL1567269 | 1.00 | FFAR1 (0.81) | FFAR1FFAR4PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250387792-A1 | COMPOSITIONS AND METHODS FOR FROTH MODIFICATION | ECOLAB USA INC (US) | 2025-12-25 | — | — | US | claimed |
| US-20250345805-A1 | COMPOSITIONS AND METHODS FOR FROTH FLOTATION OF MINERAL ORES | ECOLAB USA INC (US) | 2025-11-13 | — | — | US | claimed |
| WO-2024259191-A2 | METHOD AND COMPOSITIONS FOR TREATING SKIN DISORDERS | PHOENIX BIOTECHNOLOGY, INC. (US) | 2024-12-19 | — | — | WO | claimed |
| US-12070516-B2 | Hair styling compositions | L'OREAL (FR) | 2024-08-27 | — | — | US | claimed |
| US-20240261312-A1 | Method and compositions for treating animal viral infections | PHOENIX BIOTECHNOLOGY, INC. (US) | 2024-08-08 | — | — | US | claimed |
| EP-4387627-A1 | METHOD AND COMPOSITIONS FOR TREATING ANIMAL VIRAL INFECTIONS | Phoenix Biotechnology, Inc. (US) | 2024-06-26 | — | — | EP | claimed |
| US-20240197597-A1 | HAIR STYLING COMPOSITIONS | L'OREAL (FR) | 2024-06-20 | — | — | US | claimed |
| WO-2023235807-A2 | METHOD AND COMPOSITIONS FOR TREATING GLIOBLASTOMA WITH TRITERPENES | PHOENIX BIOTECHNOLOGY, INC. (US) | 2023-12-07 | — | — | WO | claimed |
| EP-4009981-B1 | METHOD AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTION | PHOENIX BIOTECHNOLOGY INC (US) | 2023-08-16 | — | — | EP | claimed |
| US-11702580-B2 | Coolant for cooling systems in electric vehicles having fuel cells and/or batteries containing azole derivatives and additional corrosion protectants | BASF SE (DE) | 2023-07-18 | — | — | US | claimed |
| WO-2023022866-A1 | METHOD AND COMPOSITIONS FOR TREATING ANIMAL VIRAL INFECTIONS | PHOENIX BIOTECHNOLOGY, INC. (US) | 2023-02-23 | — | — | WO | claimed |
| EP-3545047-B1 | COOLING AGENTS FOR COOLING SYSTEMS IN ELECTRIC VEHICLES WITH FUEL CELLS AND/OR BATTERIES CONTAINING AZOLE DERIVATIVES AND ADDITIONAL CORROSION INHIBITORS | BASF SE (DE) | 2023-01-11 | — | — | EP | claimed |
| US-20220362275-A1 | Method and Compositions for Treating Glioblastoma | PHOENIX BIOTECHNOLOGY, INC. (US) | 2022-11-17 | — | — | US | claimed |
| CN-110612161-B | Improved composition and process for reverse froth flotation of phosphate ores | 埃科莱布美国股份有限公司 | 2022-07-01 | — | — | CN | claimed |
| US-20220127510-A1 | COOLANT FOR COOLING SYSTEMS IN ELECTRIC VEHICLES HAVING FUEL CELLS AND/OR BATTERIES CONTAINING AZOLE DERIVATIVES AND ADDITIONAL CORROSION PROTECTANTS | BASF SE (DE) | 2022-04-28 | — | — | US | claimed |
| CN-114209711-A | Methods and compositions for treating coronavirus infection | 菲尼克斯生物技术公司 | 2022-03-22 | — | — | CN | claimed |
| US-11248155-B2 | Coolant for cooling systems in electric vehicles having fuel cells and/or batteries containing azole derivatives and additional corrosion protectants | BASF SE (DE) | 2022-02-15 | — | — | US | claimed |
| CN-112689510-B | Methods and compositions for treating coronavirus infection | 菲尼克斯生物技术公司 | 2022-02-01 | — | — | CN | claimed |
| CN-110023451-B | Coolant comprising azole derivatives and further corrosion inhibitors for cooling systems in electric vehicles with fuel cells and/or batteries | 巴斯夫欧洲公司 | 2021-06-11 | — | — | CN | claimed |
| US-20190352553-A1 | COOLANT FOR COOLING SYSTEMS IN ELECTRIC VEHICLES HAVING FUEL CELLS AND/OR BATTERIES CONTAINING AZOLE DERIVATIVES AND ADDITIONAL CORROSION PROTECTANTS | BASF SE (DE) | 2019-11-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250387792-A1 | COMPOSITIONS AND METHODS FOR FROTH MODIFICATION | MAFG, FRG1, LIPG | FFAR1 62/4885FFAR4 75/4885PPARG 35/4885 |
| US-20240197597-A1 | HAIR STYLING COMPOSITIONS | PIK3C3, POLR1C, ALKBH3 | FFAR1 130/4885FFAR4 129/4885PPARG 2096/4885 |
| US-12070516-B2 | Hair styling compositions | PIK3C3, POLR1C, ALKBH3 | FFAR1 130/4885FFAR4 129/4885PPARG 2096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.